Evidence map›Paper›PMID 40917867›Full record

ArticleColloids and surfaces. A, Physicochemical and engineering aspects2025

Noninvasive ImmunoPET imaging of PD-L1 expression in non-small cell lung cancer and bladder cancer using [

Wenpeng Huang, Fangfang Chao, Jessica C Hsu, Xinyao Sun, Todd E Barnhart, Jonathan W Engle, Xingmin Han, Lei Kang, Weibo Cai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Colloids and surfaces. A, Physicochemical and engineering aspects, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wenpeng HuangDepartment of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
Fangfang ChaoDepartment of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450052, China.
Jessica C HsuDepartments of Radiology and Medical Physics, University of Wisconsin - Madison, Madison, WI 53705, USA.
Xinyao SunDepartment of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
Todd E BarnhartDepartments of Radiology and Medical Physics, University of Wisconsin - Madison, Madison, WI 53705, USA.
Jonathan W EngleDepartments of Radiology and Medical Physics, University of Wisconsin - Madison, Madison, WI 53705, USA.
Xingmin HanDepartment of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450052, China.
Lei KangDepartment of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
Weibo CaiDepartments of Radiology and Medical Physics, University of Wisconsin - Madison, Madison, WI 53705, USA.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
NCI NIH HHS P30 CA014520
6 · The paper itself

Abstract

Purpose: ImmunoPET imaging of PD-L1 has emerged as a promising strategy for patient stratification and treatment response monitoring in immunotherapy. This study aimed to evaluate [ Materials and methods: Durvalumab was conjugated with Results: H1975 and HT1376 cells exhibited strong PD-L1 expression and high tracer uptake, while A549 and T24 cells were low in PD-L1 expression. Conclusion: [

Indexed as

Bladder cancerDurvalumabImmunoPETNon-small cell lung cancerPD-L1Zr-89

Identifiers

PMID40917867
PMCPMC12412047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.